APLM
Price
$17.99
Change
+$0.76 (+4.41%)
Updated
Dec 24 closing price
Capitalization
38.56M
Intraday BUY SELL Signals
SNTI
Price
$1.15
Change
-$0.01 (-0.86%)
Updated
Dec 24 closing price
Capitalization
30.23M
Intraday BUY SELL Signals
Interact to see
Advertisement

APLM vs SNTI

Header iconAPLM vs SNTI Comparison
Open Charts APLM vs SNTIBanner chart's image
Apollomics
Price$17.99
Change+$0.76 (+4.41%)
Volume$34.23K
Capitalization38.56M
Senti Biosciences
Price$1.15
Change-$0.01 (-0.86%)
Volume$561.98K
Capitalization30.23M
APLM vs SNTI Comparison Chart in %
APLM
Daily Signal:
Gain/Loss:
SNTI
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
APLM vs. SNTI commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLM is a Buy and SNTI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (APLM: $17.99 vs. SNTI: $1.15)
Brand notoriety: APLM and SNTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLM: 80% vs. SNTI: 29%
Market capitalization -- APLM: $38.56M vs. SNTI: $30.23M
APLM [@Biotechnology] is valued at $38.56M. SNTI’s [@Biotechnology] market capitalization is $30.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLM’s FA Score shows that 0 FA rating(s) are green whileSNTI’s FA Score has 1 green FA rating(s).

  • APLM’s FA Score: 0 green, 5 red.
  • SNTI’s FA Score: 1 green, 4 red.
According to our system of comparison, both APLM and SNTI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLM’s TA Score shows that 4 TA indicator(s) are bullish while SNTI’s TA Score has 4 bullish TA indicator(s).

  • APLM’s TA Score: 4 bullish, 2 bearish.
  • SNTI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, APLM is a better buy in the short-term than SNTI.

Price Growth

APLM (@Biotechnology) experienced а +19.30% price change this week, while SNTI (@Biotechnology) price change was -5.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLM($38.6M) has a higher market cap than SNTI($30.2M). APLM YTD gains are higher at: 84.513 vs. SNTI (-67.236). APLM has higher annual earnings (EBITDA): -56.38M vs. SNTI (-60.3M). APLM has less debt than SNTI: APLM (4.72M) vs SNTI (30.1M). APLM (0) and SNTI (0) have equivalent revenues.
APLMSNTIAPLM / SNTI
Capitalization38.6M30.2M128%
EBITDA-56.38M-60.3M93%
Gain YTD84.513-67.236-126%
P/E RatioN/A4.27-
Revenue00-
Total CashN/A12.2M-
Total Debt4.72M30.1M16%
TECHNICAL ANALYSIS
Technical Analysis
APLMSNTI
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
62%
Momentum
ODDS (%)
Bullish Trend 3 days ago
59%
Bearish Trend 3 days ago
60%
MACD
ODDS (%)
Bullish Trend 3 days ago
59%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
51%
Bearish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
45%
Bearish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
APLM
Daily Signal:
Gain/Loss:
SNTI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CELU1.320.03
+2.33%
Celularity
LRCX177.332.17
+1.24%
Lam Research Corp
BTSG37.73-0.05
-0.13%
BrightSpring Health Services
MBX32.11-0.09
-0.28%
MBX Biosciences Inc.
FNLC26.92-0.11
-0.41%
First Bancorp

APLM and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLM has been loosely correlated with SNTI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if APLM jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLM
1D Price
Change %
APLM100%
+4.41%
SNTI - APLM
47%
Loosely correlated
-0.86%
MGX - APLM
37%
Loosely correlated
+1.16%
IPHA - APLM
36%
Loosely correlated
-3.41%
PRAX - APLM
35%
Loosely correlated
-0.35%
QSI - APLM
34%
Loosely correlated
+6.50%
More

SNTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNTI has been loosely correlated with PPBT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if SNTI jumps, then PPBT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNTI
1D Price
Change %
SNTI100%
-0.86%
PPBT - SNTI
58%
Loosely correlated
-1.22%
TCRT - SNTI
47%
Loosely correlated
+3.53%
INBX - SNTI
41%
Loosely correlated
+2.92%
RXRX - SNTI
35%
Loosely correlated
+0.92%
HURA - SNTI
32%
Poorly correlated
+15.16%
More